May 9, 2018
FDA: AuroMedics recalls two lots of Ampicillin and Sulbactam for Injection
Editor's Note
The Food and Drug Administration (FDA) on May 8 announced the recall by AuroMedics Pharma (Windsor, New Jersey) of two lots of Ampicillin and Sulbactam for Injection USP, 3 g single-dose vials.
The recall was issued because of customer complaints of the presence of red particulate matter in the product that is believed to be red rubber particles from the manufacturing process.
To date, the company has not received reports of any adverse events or safety concerns attributed to the product used from these lots.
Free Daily News
- Back to Business: Budgeting for Sustainable Staffing Models in the OR
- Healthcare job gain in August offset by losses in federal government, other industries
- AHA study: HOPD Medicare patients are poorer, sicker, more rural than those seen in physician offices
- ACS, Lifesaving Technologies launch nationwide effort to expand bleeding control readiness
- Minimally invasive ICH surgery evacuates clot fast but fails to improve 6-month outcomes
- Rural hospitals face crisis under OBBBA as experts call for cohesive reform
- AMA urges health systems to act now on AI governance
- Suicide Prevention Month: Hospitals prepare for new The Joint Commission suicide prevention goal, effective 2026
- Survey: Perioperative leaders adapt to supply strain, staffing pressure, ASC growth
- Gait retraining eases knee osteoarthritis pain as effectively as medication, can delay knee surgery
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement